University of Michigan - Rogel Cancer Center — Ann Arbor, Michigan

University of Michigan - Rogel Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109-5000.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Michigan - Rogel Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.

Sponsors: Bristol-Myers Squibb, Pancreatic Cancer Action Network.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan - Rogel Cancer Center?

University of Michigan - Rogel Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan - Rogel Cancer Center conducted?

University of Michigan - Rogel Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.

Is University of Michigan - Rogel Cancer Center accredited by Crixeo Health?

University of Michigan - Rogel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan - Rogel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.